Revenue Breakdown
Composition ()
No data
Revenue Streams
Ashland Inc (ASH) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Life Sciences, accounting for 35.0% of total sales, equivalent to $162.00M. Other significant revenue streams include Personal Care & Household and Specialty Additives. Understanding this composition is critical for investors evaluating how ASH navigates market cycles within the Diversified Chemicals industry.
Profitability & Margins
Evaluating the bottom line, Ashland Inc maintains a gross margin of 30.19%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 12.16%, while the net margin is 6.92%. These profitability ratios, combined with a Return on Equity (ROE) of -34.45%, provide a clear picture of how effectively ASH converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, ASH competes directly with industry leaders such as COCO and TR. With a market capitalization of $2.85B, it holds a significant position in the sector. When comparing efficiency, ASH's gross margin of 30.19% stands against COCO's 37.66% and TR's 34.12%. Such benchmarking helps identify whether Ashland Inc is trading at a premium or discount relative to its financial performance.
